as of 03-04-2026 3:42pm EST
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | THE WOODLANDS |
| Market Cap: | 547.4M | IPO Year: | 2000 |
| Target Price: | $3.23 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.10 | EPS Growth: | 21.25 |
| 52 Week Low/High: | $0.32 - $1.83 | Next Earning Date: | 05-04-2026 |
| Revenue: | $31,081,000 | Revenue Growth: | 2481.48% |
| Revenue Growth (this year): | 56.61% | Revenue Growth (next year): | -56.07% |
| P/E Ratio: | -15.95 | Index: | N/A |
| Free Cash Flow: | -179811000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$1.49
Shares
2,000
Total Value
$2,980.00
Owned After
1,906,186
SEC Form 4
Director
Avg Cost/Share
$1.47
Shares
100,000
Total Value
$147,000.00
Owned After
1,906,186
SEC Form 4
Director
Avg Cost/Share
$1.48
Shares
100,000
Total Value
$147,790.00
Owned After
1,906,186
SEC Form 4
Director
Avg Cost/Share
$1.44
Shares
50,000
Total Value
$71,965.00
Owned After
1,906,186
SEC Form 4
Director
Avg Cost/Share
$1.32
Shares
133,688
Total Value
$176,468.16
Owned After
1,906,186
SEC Form 4
Director
Avg Cost/Share
$1.31
Shares
76,857
Total Value
$100,544.33
Owned After
1,906,186
SEC Form 4
Director
Avg Cost/Share
$1.31
Shares
57,952
Total Value
$75,876.55
Owned After
1,906,186
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.30
Shares
1,538,462
Total Value
$2,000,000.60
Owned After
1,538,462
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| DEBBANE RAYMOND | LXRX | Director | Feb 25, 2026 | Buy | $1.49 | 2,000 | $2,980.00 | 1,906,186 | |
| DEBBANE RAYMOND | LXRX | Director | Feb 23, 2026 | Buy | $1.47 | 100,000 | $147,000.00 | 1,906,186 | |
| DEBBANE RAYMOND | LXRX | Director | Feb 20, 2026 | Buy | $1.48 | 100,000 | $147,790.00 | 1,906,186 | |
| DEBBANE RAYMOND | LXRX | Director | Feb 19, 2026 | Buy | $1.44 | 50,000 | $71,965.00 | 1,906,186 | |
| DEBBANE RAYMOND | LXRX | Director | Feb 18, 2026 | Buy | $1.32 | 133,688 | $176,468.16 | 1,906,186 | |
| DEBBANE RAYMOND | LXRX | Director | Feb 17, 2026 | Buy | $1.31 | 76,857 | $100,544.33 | 1,906,186 | |
| DEBBANE RAYMOND | LXRX | Director | Feb 13, 2026 | Buy | $1.31 | 57,952 | $75,876.55 | 1,906,186 | |
| Invus Global Management, LLC | LXRX | Director, 10% Owner | Feb 2, 2026 | Buy | $1.30 | 1,538,462 | $2,000,000.60 | 1,538,462 |
See how LXRX stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "LXRX Lexicon Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.